Answer
No. Breastfeeding should be stopped during treatment because dasatinib may enter breast milk and a risk to the infant cannot be excluded.
Sources for this answer
- Dasatinib 100mg Film-Coated Tablets — Current selected SmPCemc · Summary of Product Characteristics
- Sprycel 10 mg/mL powder for oral suspension — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.